Peter Curtin

Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients

Hillard M. Lazarus, Omer N. Koç, Steven M. Devine et al. · Biology of Blood and Marrow Transplantation · 2005 · 796 citations · Full text

Medicine, Hematology, Immunology +17

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5q

Azra Raza, James A. Reeves, Eric J. Feldman et al. · Blood · 2007 · 423 citations · Full text

Medicine, Hematology, Oncology +16

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

Jerald P. Radich, Michael W. Deininger, Camille N. Abboud et al. · Journal of the National Comprehensive Cancer Network · 2018 · 282 citations · Full text

Medicine, Hematology, Oncology +15

Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics

Daniel J. DeAngelo, Richard M. Stone, Mark Heaney et al. · Blood · 2006 · 275 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Peter Westervelt, Randy A. Brown, Douglas R. Adkins et al. · Blood · 2001 · 248 citations

Medicine, Hematology, Oncology +12